RespiriTB-1136142 In vitro activity report for new anti-bacterial compounds

Summary

The In vitro activity report for new anti-bacterial compounds will summarize the results of in vitro activity of newly identified compounds within the project against intracellular (MDR)-Mtb strains in human cells.

More information & hyperlinks

Web resources:

https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50bbdba2d&appId=PPGMS

Associated projects

RespiriTB - Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Organisations

Not specified